A detailed history of Raiffeisen Bank International Ag transactions in Eli Lilly & CO stock. As of the latest transaction made, Raiffeisen Bank International Ag holds 151,223 shares of LLY stock, worth $155 Million. This represents 1.46% of its overall portfolio holdings.

Number of Shares
151,223
Previous 145,246 4.12%
Holding current value
$155 Million
Previous $115 Billion 4.51%
% of portfolio
1.46%
Previous 1.71%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025

BUY
$625.65 - $812.69 $3.74 Million - $4.86 Million
5,977 Added 4.12%
151,223 $110 Billion
Q2 2025

Aug 11, 2025

SELL
$713.71 - $898.95 $15.4 Million - $19.4 Million
-21,609 Reduced 12.95%
145,246 $115 Billion
Q1 2025

May 09, 2025

SELL
$725.72 - $929.72 $2.41 Million - $3.08 Million
-3,316 Reduced 1.95%
166,855 $137 Billion
Q4 2024

Feb 14, 2025

BUY
$727.2 - $932.06 $124 Million - $159 Million
170,171 New
170,171 $132 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $971B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Raiffeisen Bank International Ag Portfolio

Follow Raiffeisen Bank International Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raiffeisen Bank International Ag, based on Form 13F filings with the SEC.

News

Stay updated on Raiffeisen Bank International Ag with notifications on news.